News

No increased cancer risk in children born after assisted conception


 

AT ESHRE 2013

The increased risk for rare childhood tumors seen in the U.K. study and in the CoNARTaS study could even be down to chance as the numbers used in the analyses are relatively small.

"When we subdivide by cancer types, our numbers get smaller and smaller, and therefore the role of chance is increased," Dr. Williams commented. "The answer is to keep studying this area, perhaps do another systematic review, putting all of the results together, and then we will have more reliable findings."

Dr. Williams added: "So far, it looks like the results are really positive for the many children born after assisted conception."

Cancer Research U.K. funded the U.K. study. The U.K. National Institute of Health Research provided funding to Dr. Williams. CoNARTaS is supported by ESHRE, Sahlgrenska University Hospital, the University of Copenhagen, the Danish Agency for Science Technology and Innovation, and the Nordic Federation of Societies of Obstetrics and Gynecology. Dr. Williams and Dr. Pinborg said they had no relevant financial disclosures.

Pages

Recommended Reading

Adding bevacizumab to chemo prolongs life in advanced cervical cancer
MDedge ObGyn
Palbociclib continues on fast track to potential FDA approval
MDedge ObGyn
Study confirms benefits of 10 years of tamoxifen
MDedge ObGyn
Weekly adjuvant paclitaxel for breast cancer has less toxicity
MDedge ObGyn
Gene mutations found in 22% of African American breast cancer patients
MDedge ObGyn
How will sequestration affect American cancer care?
MDedge ObGyn
Supreme Court: Human genes cannot be patented
MDedge ObGyn
BOLERO-3: Everolimus tweaks trastuzumab-resistant metastatic breast cancer
MDedge ObGyn
Opioid overdose deaths skyrocket in women
MDedge ObGyn
Updated guideline urges discussion of breast cancer chemoprevention
MDedge ObGyn